Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MediSense Precision-G is firm's entry into U.S. clinical blood glucose testing market.

This article was originally published in The Gray Sheet

Executive Summary

MEDISENSE ENTERING U.S. CLINICAL BLOOD GLUCOSE TESTING MARKET WITH PRECISION-G biosensor blood glucose monitor, which will begin shipping domestically and internationally within the next two months. MediSense introduced both the Precision-G and its Precision Q-I-D, available in a home kit for patients and a hospital tray format, at the annual meeting of the American Diabetes Association the week of June 10.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel